- Home
- AMRC vs ORIC Comparison
AMRC vs ORIC Comparison
Compare AMRC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMRC | ORIC |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AMRC | ORIC |
|---|---|---|
| Price | $26.37 | $11.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $37.88 | $20.00 |
| AVG Volume (30 Days) | 418.0K | ★ 1.4M |
| Earning Date | 03-02-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.67 |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $1,769,928,000.00 | N/A |
| Revenue This Year | $10.66 | N/A |
| Revenue Next Year | $8.93 | N/A |
| P/E Ratio | $54.77 | ★ N/A |
| Revenue Growth | ★ 28.76 | N/A |
| 52 Week Low | $8.49 | $3.90 |
| 52 Week High | $44.93 | $14.93 |
Technical Indicators
Market Signals| Indicator | AMRC | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 41.58 | 44.94 |
| Support Level | $26.29 | $9.88 |
| Resistance Level | $31.12 | $12.12 |
| Average True Range (ATR) | 1.60 | 0.81 |
| MACD | 0.03 | -0.28 |
| Stochastic Oscillator | 30.56 | 20.24 |
Price Performance
Historical ComparisonAbout AMRC Ameresco Inc.
Ameresco Inc is an energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the energy transition. Its comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. Its solutions range from upgrades to facility's energy infrastructure to the development, construction and operation of renewable energy plants combined with tailored financial solutions. Its segments include North America Regions, U.S. Federal, Renewable Fuels, Europe, and Others. The majority of the revenue is derived from North America Regions segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.